Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type
Clinical trial NCT06052254 · RECRUITING
Trial details
- NCT number
- NCT06052254
- Sponsor
- Teikoku Pharma USA, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-16
- Primary completion
- 2027-05-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.